Management Accounting

ARTEMIZA ZARAGOZA

**** ***** *****, *** *** Phone: 858-***-****

San Diego, CA 92122 ******@*********.***

SUMMARY

An effective senior capital accountant with 10+ years of progressive experience in the

Biopharmaceutical Industry, including Big 4 Accounting advising customers in all aspects of state,

local, and capital asset matters. Proven track record in the areas of operational & financial

performance management, continuous improvement, resource planning, capital asset matters,

construction projects, and capital disposals and/or impairments while working within budgetary

constraints. Expertise in the following areas:

• •

Budgeting & Forecasting Capital Project Approvals and Rejections

• •

Operational & Financial Metrics Organizational, detail oriented and adaptable to

• innovations

Balance Sheet Analysis

•

• M&A Integration

Managed three large ($700+m)

•

capital projects simultaneously Expertise in Relationship and Team Building

• •

Strategic Business Planning Oracle, Hyperion, JD Edwards, Microsoft

Office Applications (Excel, Word, PowerPoint)

PROFESSIONAL EXPERIENCE

AMYLIN PHARMACEUTICALS INC., SAN DIEGO, CA 2008 – 2011

Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery,

development, and commercialization of drug candidates for the treatment of diabetes, obesity,

and other diseases.

Senior Analyst, Commercial Effectiveness 2011 - 2011

Worked with business on negotiating vendor service and data license agreements, and support to

the Accelerated Procurement Savings Initiative and helped improve Commercial contracting

processes.

Senior Accountant, Finance 2008 - 2011

Capital and Property Accounting, Fixed Asset Management, Depreciation Analysis, and Property

Tax Analysis and Reporting.

Revamped, implemented, maintained, reconciled and managed all accounting policies and

processes for all corporate asset spending including patents, within the fixed asset module in

E1/JD Edwards and provided optimal capital reporting for end-users and management report.

Created policies and procedures, new asset categorizations, SOX controls, standardized

forms, and trained Ohio accounting staff for new manufacturing facility built in Ohio.

Set-up of assets, projects, monthly depreciation run, capital requisition review and approval,

manage SOX requirements, including physical inventory and verbiage updates, CIP and FA

roll-forwards and reconciliations, capitalized interest, and depreciation planning and

forecasting analysis.

Exceeded Accelerated Procurement Savings Commercial initiative by 40% in 1/2 the time.

Uncovered a $5.5m property tax refund ($1.1m immediate refund, and $4.4m in projected tax

savings).

BIOGEN IDEC INC., SAN DIEGO, CA 2002 – 2008

Biogen Idec Inc., a biotechnology company, discovers, develops, manufactures, and markets

therapeutics in the areas of neurology, immunology, hemophilia, and oncology in the United

States and internationally.

Senior Accountant/Analyst, Finance 2002 - 2008

Provided financial support to 40+ cost centers within the largest strategic business unit

(Pharmaceutical Operational &Technical), and capital analysis to all West Coast operations.

Capital coordinator for three large construction projects totaling $700+m and managed the

integrity of an additional $600+m in fixed assets located in the West Coast and backup for

global CapEx.

Provided capital analysis, project cash flows, asset utilization, communicated corporate goals

and targets, budget analysis, formalized financial policies and procedures, analyses on

financial results, capital tax audits, capital leases and performed ad hoc reports as required

and requested by customers and/or management, including white papers, 10k & Q verbiage,

etc. (Analyses were for both CapEx and OpEx).

Prepared and filed annual personal property tax returns, and negotiated base year valuations

on both the $500m manufacturing and $200m corporate research campuses with the County

of San Diego Assessor's Office. Negotiated favorable trend tables and $35+m of non-

assessable cost for a $5+m savings in property taxes annually.

Co-coordinated the merger of Idec Pharmaceuticals fixed asset general ledger balances,

processes and practices with Biogen during the November 2003 merger. Over 100+fixed

asset accounting software platforms and processes changed in less than two months,

including the software conversion from Ross to Oracle which included a new chart of account

hierarchy.

DELOITTE & TOUCHE LLP, COSTA MESA, CA 2001 – 2002

"Deloitte” is the brand under which tens of thousands of dedicated professionals in independent

firms throughout the world collaborate to provide audit, consulting, financial advisory, risk

management and tax services to selected clients.

Senior Tax Consultant 2001 - 2002

Property tax consulting for US clients.

Evaluated personal property tax consequences for clients, including tax planning, National

compliance, as well as advising on tax ramifications of acquisitions, divestitures and legislative

initiatives.

Analyzed data for the purpose of optimization of tax savings, by jurisdictional profiling; ghost

asset suppression, asset scrubs, identification of exemptions, and fair market evaluations.

Effective in negotiating techniques and a command of the industry language, which generated

over $8m in tax dollar refunds and pro-active tax savings.

EDUCATION and AWARDS

Bachelor of Science in Business Administration – San Diego State University

Major: Accounting Minor: Spanish

ARTEMIZA ZARAGOZA PAGE TWO

Accounting Principles Course – UCSD Extension Studies

Management Courses – AMA and other organizations

2011 Cultural Believer Award - Amylin Pharmaceuticals Inc.

Contact this candidate